Refined R&D indicators for pharmaceutical industry

Abstract

For the sake of providing evidences that contribute to policy making or strategy planning in pharmaceutical industry, we tried to create new R&D indicators to foresight the picture of pharmaceutical industries. We found that R&D pipelines can be good drug-R&D-indicator. We also show new drug-patent-indicators for identifying patents related with pharmaceutical entities' R&D progress ("Pre-clinical" → "Phase 1" → "Phase 2" → "Phase 3"→ "Filed "→ "Approved" → "Marketed"). IPC Count, forward citations, and Citations to Non-Patent Literature are found as new drug-patent-indicators. Not only R&D pipelines but also patents extracted by new drug-patent-indicators are considered to foresight pharmaceutical industries' potential of creating new drugs. © 2014 Springer-Verlag Berlin Heidelberg.